Gnéithe struchtúracha monarchana cille

Wed May 18 15:05:09 CST 2022

Tá forbairt na teicneolaíochta cultúir cille an-aibí go dtí seo, agus úsáideadh go forleathan é in ullmhú antasubstaintí monaclónacha, táirgeadh vacsaíní, taighde eolaíoch agus réimsí eile. Éilíonn cultúr cille cabhair ó earraí inchaite cille. Tá cineálacha éagsúla earraí inchaite ar an margadh. Ina measc, is cineál inchaite é an cell factory le struchtúr speisialta.

Difriúil ó ábhair inchaite eile de chineál buidéal, tá Cell Factory inchaite speisialta le struchtúr ilchiseal. I measc na sonraíochtaí coitianta tá 1 ciseal, 2 sraithe, 5 sraithe, 10 sraithe, 40 sraithe, etc. Nuair a bhíonn cealla á saothrú, déantar an meán a dhoirteadh isteach sna sraitheanna istigh, agus tá na cealla ceangailte leis an mbun chun fás agus iolrú. Mar gheall ar an líon ard sraitheanna 10-ciseal agus 40-ciseal, tá sé deacair oibriú tar éis an mheán a chur leis. Go ginearálta, úsáidtear é in éineacht le shaker uathoibrithe. Féadann sé ríomhchlárú, uathoibriú agus éifeachtúlacht chultúr na gcealla ar scála mór a bhaint amach, rud a fhágann go laghdaítear go mór déine saothair agus dlús. agus an baol éillithe a laghdú. I dtéarmaí réimse cultúir, tá limistéar cultúir mhonarcha cealla 10-ciseal comhionann le 36 fleascán cultúir T-175. Tá na sraitheanna ceangailte le próiseas táthú speisialta, rud a d'fhéadfadh cobhsaíocht an chomhshaoil ​​​​inmheánaigh a chinntiú agus timpeallacht fáis mhaith a chruthú d'fhás cille.

Faoi láthair, tá monarchana cille tar éis roinnt ábhar inchaite cultúir cille traidisiúnta a athsholáthar de réir a chéile agus a bheith ina n-earraí inchaite príomhshrutha i. réimsí na bithchógaisíochta agus an taighde eolaíoch. Le forbairt go mear ar an tionscal bithchógaisíochta, is fiú súil a chaitheamh ar spás fáis an inchaite seo sa todhchaí.

At present, cell factories have gradually replaced some traditional cell culture consumables and become mainstream consumables in the fields of biopharmaceuticals and scientific research. With the rapid development of the biopharmaceutical industry, the future growth space of this consumable is worth looking forward to.

The FAI climbed 5.9 percent year-on-year in the first 11 months of 2018, quickening from the 5.7-percent growth in Jan-Oct, the National Bureau of Statistics (NBS) said Friday in an online statement.

The key indicator of investment, dubbed a major growth driver, hit the bottom in August and has since started to rebound steadily.

In the face of emerging economic challenges home and abroad, China has stepped up efforts to stabilize investment, in particular rolling out measures to motivate private investors and channel funds into infrastructure.

Friday's data showed private investment, accounting for more than 60 percent of the total FAI, expanded by a brisk 8.7 percent.

NBS spokesperson Mao Shengyong said funds into weak economic links registered rapid increases as investment in environmental protection and agriculture jumped 42 percent and 12.5 percent respectively, much faster than the average.

In breakdown, investment in high-tech and equipment manufacturing remained vigorous with 16.1-percent and 11.6-percent increases respectively in the first 11 months. Infrastructure investment gained 3.7 percent, staying flat. Investment in property development rose 9.7 percent, also unchanged.